Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.29 -0.51 (-1.31%) Market Cap: 5.59 Bil Enterprise Value: 4.90 Bil PE Ratio: 0 PB Ratio: 18.86 GF Score: 70/100

Ionis Pharmaceuticals Inc Investor Day Transcript

Dec 09, 2021 / 04:00PM GMT
Release Date Price: $30.28 (-5.99%)
Jennifer Capuzelo

Good morning. I'm Jennifer Capuzelo, Director of Investor Relations, and I'd like to welcome you to the Ionis 2021 Investor Day. Following our prepared remarks today, we will host a question-and-answer session. (Operator Instructions) Additionally, today's presentation is being recorded, and a replay will be available on the Ionis website shortly.

Before we continue, please be aware that during today's presentation, we will be making forward-looking statements, which are based on our current expectations and beliefs. Please consult the risk factors discussed in our SEC filings for additional detail.

And with that, I'll turn it over to CEO, Brett Monia.

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Thank you very much, Jennifer. And most of all, thank you to everybody joining us for today remotely out there for today's Ionis Investor Day presentation.

We're very proud of some of our key strategic decisions that we've made over the last couple of years to bring Ionis to become a -- forward to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot